Calvert Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,691
Closed -$848K 336
2016
Q4
$848K Sell
7,691
-83
-1% -$9.22K 0.03% 412
2016
Q3
$918K Buy
7,774
+547
+8% +$64.5K 0.03% 395
2016
Q2
$809K Buy
7,227
+86
+1% +$9.26K 0.03% 393
2016
Q1
$719K Buy
7,141
+711
+11% +$68.2K 0.03% 394
2015
Q4
$683K Buy
6,430
+1,175
+22% +$121K 0.03% 376
2015
Q3
$490K Buy
5,255
+264
+5% +$27.3K 0.02% 360
2015
Q2
$520K Sell
4,991
-270
-5% -$28.1K 0.02% 359
2015
Q1
$570K Buy
5,261
+1,388
+36% +$143K 0.04% 327
2014
Q4
$359K Buy
3,873
+248
+7% +$21.9K 0.02% 417
2014
Q3
$317K Buy
+3,625
New +$328K 0.02% 431

Other funds holding LH

Calvert Investment Management's LH Position: Q1 2017 in Review

Calvert Investment Management sold out of Labcorp (LH) in Q1 2017, closing a stake of 7,691 shares — an estimated $848K sold.

Calvert Investment Management first reported a position in LH in Q3 2014 and held it in 10 quarters. The position peaked at $918K in Q3 2016. 693 funds tracked by Wall St. Rank hold LH as of Q1 2017.

  • Calvert Investment Management reported no remaining Labcorp position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 7,691 Labcorp shares in Q1 2017, an estimated $848K.
  • Calvert Investment Management first reported a position in Labcorp in Q3 2014 and held it in 10 quarters.
  • Calvert Investment Management's Labcorp position peaked at $918K in Q3 2016.
  • 693 funds tracked by Wall St. Rank held Labcorp as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.